|
GB0207440D0
|
|
Tolerogenic antigen-presenting cells
|
|
GB0207442D0
|
|
Insulin-secreting cells for use in diabetes therapy
|
|
US2003088881A1
|
|
Stabilization of milk from transgenic animals
|
|
EP1194570A1
|
|
Fusion proteins incorporating lysozyme
|
|
NZ530425A
|
|
Genetic modification of somatic cells and uses thereof
|
|
NZ514620A
|
|
Genetic modification of somatic cells and uses thereof
|
|
AU1395600A
|
|
Stabilisation of milk from transgenic animals
|
|
AU6104799A
|
|
Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
|
|
GB9917023D0
|
|
Methods
|
|
GB9914733D0
|
|
Methods
|
|
AU4380599A
|
|
Methods for production of recombinant polypeptides
|
|
GB9905033D0
|
|
Methods
|
|
GB9825374D0
|
|
Method
|
|
GB9820845D0
|
|
Purification
|
|
GB9820847D0
|
|
Method
|
|
GB9820848D0
|
|
Purification
|
|
GB9820846D0
|
|
Purification
|
|
GB9820447D0
|
|
Biological manipulation
|
|
GB9813912D0
|
|
Methods
|
|
GB9806966D0
|
|
Bioloically modified device
|
